Your browser doesn't support javascript.
loading
Flash glucose monitoring system in special situations.
Rigon, Fernanda Augustini; Ronsoni, Marcelo Fernando; Vianna, André Gustavo Daher; de Lucca Schiavon, Leonardo; Hohl, Alexandre; van de Sande-Lee, Simone.
Afiliação
  • Rigon FA; Programa de Pós-graduação em Ciências Médicas, Universidade Federal de Santa Catarina, Florianópolis, SC, Brasil, fernandarigon@hotmail.com.
  • Ronsoni MF; Departamento de Clínica Médica, Universidade Federal de Santa Catarina, Florianópolis, SC, Brasil.
  • Vianna AGD; Centro de Diabetes de Curitiba, Departamento de Doenças Endócrinas, Hospital Nossa Senhora das Graças, Curitiba, PR, Brasil.
  • de Lucca Schiavon L; Departamento de Clínica Médica, Universidade Federal de Santa Catarina, Florianópolis, SC, Brasil.
  • Hohl A; Departamento de Clínica Médica, Universidade Federal de Santa Catarina, Florianópolis, SC, Brasil.
  • van de Sande-Lee S; Departamento de Clínica Médica, Universidade Federal de Santa Catarina, Florianópolis, SC, Brasil.
Arch Endocrinol Metab ; 66(6): 883-894, 2022 Nov 17.
Article em En | MEDLINE | ID: mdl-35657123
The management of diabetes mellitus (DM) requires maintaining glycemic control, and patients must keep their blood glucose levels close to the normal range to reduce the risk of microvascular complications and cardiovascular events. While glycated hemoglobin (A1C) is currently the primary measure for glucose management and a key marker for long-term complications, it does not provide information on acute glycemic excursions and overall glycemic variability. These limitations may even be higher in some special situations, thereby compromising A1C accuracy, especially when wider glycemic variability is expected and/or when the glycemic goal is more stringent. To attain adequate glycemic control, continuous glucose monitoring (CGM) is more useful than self-monitoring of blood glucose (SMBG), as it is more convenient and provides a greater amount of data. Flash Glucose Monitoring (isCGM /FGM) is a widely accepted option of CGM for measuring interstitial glucose levels in individuals with DM. However, its application under special conditions, such as pregnancy, patients on hemodialysis, patients with cirrhosis, during hospitalization in the intensive care unit and during physical exercise has not yet been fully validated. This review addresses some of these specific situations in which hypoglycemia should be avoided, or in pregnancy, where strict glycemic control is essential, and the application of isCGM/FGM could alleviate the shortcomings associated with poor glucose control or high glycemic variability, thereby contributing to high-quality care.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Diabetes Mellitus Tipo 1 / Hipoglicemia Limite: Female / Humans / Pregnancy Idioma: En Revista: Arch Endocrinol Metab Ano de publicação: 2022 Tipo de documento: Article País de publicação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Diabetes Mellitus Tipo 1 / Hipoglicemia Limite: Female / Humans / Pregnancy Idioma: En Revista: Arch Endocrinol Metab Ano de publicação: 2022 Tipo de documento: Article País de publicação: Brasil